Kentucky Attorney General Jack Conway announced Kentucky’s participation on last Friday (Feb. 28, 2014) in a more than $3.8 million multi-state and federal settlement with a pharmacy specializing in dispensing drugs to nursing homes.
Omnicare Inc. allegedly received kickbacks from Amgen Inc. to promote the drug Aranesp, a drug used to treat anemia caused by chemotherapy or kidney failure. Between Sept. 1, 2003 and June 30, 2005, Omnicare allegedly solicited and received kickbacks in the form of discounts, grants, market share rebates, consulting services, speaker fees, travel and dinners. The alleged kickbacks were offered in exchange for Omnicare influencing healthcare providers’ selection and use of Aranesp in long-term care facilities.
Omnicare also allegedly implemented therapeutic interchange programs meant to switch patients from a competitor drug to Aranesp and allegedly caused false and/or fraudulent claims for Aranesp to be submitted to federal and state Medicaid programs.
Keep reading this article at: http://legalnewsline.com/news/247651-omnicare-to-pay-3-8m-in-false-claims-act-settlement-with-feds-states
